HUMA
Humacyte·NASDAQ
--
--(--)
--
--(--)
HUMA Filings
Filing Date
Form Description
Form Type
2026-03-27
Humacyte, Inc.(HUMA)-20260327-2025 Q4 Earnings call transcript
Earnings Call
2026-03-27 · Earnings Call
Humacyte, Inc.(HUMA)-20260327-2025 Q4 Earnings call transcript
2026-03-27
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-27 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-24
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-24 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-19
Form 8-K - Current report
Key Events
2026-03-19 · Key Events
Form 8-K - Current report
2026-03-19
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-19 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-19
Form 8-K - Current report
Key Events
2026-03-19 · Key Events
Form 8-K - Current report
2026-01-09
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-09 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-12-16
Form 8-K - Current report
Key Events
2025-12-16 · Key Events
Form 8-K - Current report
2025-12-16
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-16 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-15
Form 8-K - Current report
Key Events
2025-12-15 · Key Events
Form 8-K - Current report
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
